Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation

被引：39
作者：
Mautner, V. -F. [1 ]
Nguyen, R. [1 ]
Knecht, R. [2 ]
Bokemeyer, C. [3 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Ear Nose & Throat, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Oncol Hematol Canc Ctr, Hamburg, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷 / 11期
关键词：
D O I：
10.1093/annonc/mdq566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2294 / 2295
页数：3
相关论文
共 4 条
[1]   Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis [J].
An, Mao Mao ;
Zou, Zui ;
Shen, Hui ;
Liu, Ping ;
Chen, Meng Li ;
Cao, Yong Bing ;
Jiang, Yuan Ying .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (08) :813-821
[2]   Clinical pharmacokinetics of bevacizumab in patients with solid tumors [J].
Lu, Jian-Feng ;
Bruno, Rene ;
Eppler, Steve ;
Novotny, William ;
Lum, Bert ;
Gaudreault, Jacques .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) :779-786
[3]   Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2 [J].
Mautner, Victor-Felix ;
Nguyen, Rosa ;
Kutta, Hannes ;
Fuensterer, Carsten ;
Bokemeyer, Carsten ;
Hagel, Christian ;
Friedrich, Reinhard E. ;
Panse, Jens .
NEURO-ONCOLOGY, 2010, 12 (01) :14-18
[4]   Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2 [J].
Plotkin, Scott R. ;
Stemmer-Rachamimov, Anat O. ;
Barker, Fred G., II ;
Halpin, Chris ;
Padera, Timothy P. ;
Tyrrell, Alex ;
Sorensen, A. Gregory ;
Jain, Rakesh K. ;
di Tomaso, Emmanuelle .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04) :358-367
1